Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
-14.4%/yr
Annual compound
Percentile
P57
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00 | -18.2% |
| 2024 | 0.00 | -13.5% |
| 2023 | 0.00 | -11.3% |
| 2022 | 0.00 | +1657.9% |
| 2021 | 0.00 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |